The seminar addressed issues such as the human cost of zoonoses, trends in food-borne diseases, challenges and lessons learnt from epidemiological investigations on the 2011 E.coli outbreak and salmonella controls.
On 3 October 2011 European Centre for Disease Prevention and Control (ECDC) and representatives of the European Vaccine Manufacturers met at ECDC in Stockholm for a regular scheduled meeting about the use of vaccines for prevention of seasonal and pandemic influenza. ECDC Director Marc Sprenger opened the meeting and ECDC influenza experts held different presentations, such as burden of influenza disease in the EU, risk groups for severe influenza disease, personal protective measures, pandemic influenza preparedness, seasonal influenza vaccines, communication.
The Declarations of Interest for ECDC Influenza Staff and the ECDC Director are available here under ECDC Transparency.
The ERS Annual Congress brings together the world's respiratory experts and professionals to meet, exchange views and share knowledge covering all aspects of respiratory medicine, novelties and most recent data presentations.
In the context of the ongoing outbreak of Shiga toxin-producing E. coli (STEC) that affects by now citizens from 13 EU member states, it is crucial not only to align the efforts regarding investigation and control of the outbreak but also to share knowledge among practitioners across Europe on the patho-physiological and clinical characteristics of infection caused by this unusual epidemic strain, and review patient management options.
Objective of meeting: To build consensus on best practices for influenza seroprevalence studies that will optimize the timing, quality, comparability and combinability of data